Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions

Michael C. Stauder, O. Kenneth MacDonald, Kenneth R. Olivier, Jason A. Call, Kyle Lafata, Charles S. Mayo, Robert C. Miller, Paul D. Brown, Heather J. Bauer, Yolanda Isabel Garces

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background and purpose: Identify the incidence of early pulmonary toxicity in a cohort of patients treated with lung stereotactic body radiation therapy (SBRT) on consecutive treatment days. Material and methods: A total of 88 lesions in 84 patients were treated with SBRT in consecutive daily fractions (Fx) for medically inoperable non-small cell lung cancer or metastasis. The incidence of pneumonitis was evaluated and graded according to the NCI CTCAE v3.0. Results: With a median follow-up of 15.8 months (range 2.5-28.6), the median age at SBRT was 71.8 years (range 23.8-87.8). 47 lesions were centrally located and 41 were peripheral. Most central lesions were treated with 48 Gy in 4 Fx, and most peripheral lesions with 54 Gy in 3 Fx. The incidence of grade ≥2 pneumonitis was 12.5% in all patients treated, and 14.3% among the subset of patients treated with 54 Gy in 3 Fx. A total of two grade 3 toxicities were seen as one grade 5 toxicity in a patient treated for recurrence after pneumonectomy. Conclusions: Treating both central and peripheral lung lesions with SBRT in consecutive daily fractions in this cohort was well tolerated and did not cause excessive early pulmonary toxicity.

Original languageEnglish (US)
Pages (from-to)166-171
Number of pages6
JournalRadiotherapy and Oncology
Volume99
Issue number2
DOIs
StatePublished - May 2011

Fingerprint

Radiotherapy
Lung
Incidence
Pneumonia
Pneumonectomy
Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Recurrence
Therapeutics

Keywords

  • Lung neoplasms
  • Non-small cell lung carcinoma
  • Radiation pneumonitis
  • Radiotherapy
  • Stereotactic body radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. / Stauder, Michael C.; MacDonald, O. Kenneth; Olivier, Kenneth R.; Call, Jason A.; Lafata, Kyle; Mayo, Charles S.; Miller, Robert C.; Brown, Paul D.; Bauer, Heather J.; Garces, Yolanda Isabel.

In: Radiotherapy and Oncology, Vol. 99, No. 2, 05.2011, p. 166-171.

Research output: Contribution to journalArticle

Stauder, MC, MacDonald, OK, Olivier, KR, Call, JA, Lafata, K, Mayo, CS, Miller, RC, Brown, PD, Bauer, HJ & Garces, YI 2011, 'Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions', Radiotherapy and Oncology, vol. 99, no. 2, pp. 166-171. https://doi.org/10.1016/j.radonc.2011.04.002
Stauder, Michael C. ; MacDonald, O. Kenneth ; Olivier, Kenneth R. ; Call, Jason A. ; Lafata, Kyle ; Mayo, Charles S. ; Miller, Robert C. ; Brown, Paul D. ; Bauer, Heather J. ; Garces, Yolanda Isabel. / Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. In: Radiotherapy and Oncology. 2011 ; Vol. 99, No. 2. pp. 166-171.
@article{547d89fb29e24806bf9b46a55eb44f28,
title = "Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions",
abstract = "Background and purpose: Identify the incidence of early pulmonary toxicity in a cohort of patients treated with lung stereotactic body radiation therapy (SBRT) on consecutive treatment days. Material and methods: A total of 88 lesions in 84 patients were treated with SBRT in consecutive daily fractions (Fx) for medically inoperable non-small cell lung cancer or metastasis. The incidence of pneumonitis was evaluated and graded according to the NCI CTCAE v3.0. Results: With a median follow-up of 15.8 months (range 2.5-28.6), the median age at SBRT was 71.8 years (range 23.8-87.8). 47 lesions were centrally located and 41 were peripheral. Most central lesions were treated with 48 Gy in 4 Fx, and most peripheral lesions with 54 Gy in 3 Fx. The incidence of grade ≥2 pneumonitis was 12.5{\%} in all patients treated, and 14.3{\%} among the subset of patients treated with 54 Gy in 3 Fx. A total of two grade 3 toxicities were seen as one grade 5 toxicity in a patient treated for recurrence after pneumonectomy. Conclusions: Treating both central and peripheral lung lesions with SBRT in consecutive daily fractions in this cohort was well tolerated and did not cause excessive early pulmonary toxicity.",
keywords = "Lung neoplasms, Non-small cell lung carcinoma, Radiation pneumonitis, Radiotherapy, Stereotactic body radiotherapy",
author = "Stauder, {Michael C.} and MacDonald, {O. Kenneth} and Olivier, {Kenneth R.} and Call, {Jason A.} and Kyle Lafata and Mayo, {Charles S.} and Miller, {Robert C.} and Brown, {Paul D.} and Bauer, {Heather J.} and Garces, {Yolanda Isabel}",
year = "2011",
month = "5",
doi = "10.1016/j.radonc.2011.04.002",
language = "English (US)",
volume = "99",
pages = "166--171",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions

AU - Stauder, Michael C.

AU - MacDonald, O. Kenneth

AU - Olivier, Kenneth R.

AU - Call, Jason A.

AU - Lafata, Kyle

AU - Mayo, Charles S.

AU - Miller, Robert C.

AU - Brown, Paul D.

AU - Bauer, Heather J.

AU - Garces, Yolanda Isabel

PY - 2011/5

Y1 - 2011/5

N2 - Background and purpose: Identify the incidence of early pulmonary toxicity in a cohort of patients treated with lung stereotactic body radiation therapy (SBRT) on consecutive treatment days. Material and methods: A total of 88 lesions in 84 patients were treated with SBRT in consecutive daily fractions (Fx) for medically inoperable non-small cell lung cancer or metastasis. The incidence of pneumonitis was evaluated and graded according to the NCI CTCAE v3.0. Results: With a median follow-up of 15.8 months (range 2.5-28.6), the median age at SBRT was 71.8 years (range 23.8-87.8). 47 lesions were centrally located and 41 were peripheral. Most central lesions were treated with 48 Gy in 4 Fx, and most peripheral lesions with 54 Gy in 3 Fx. The incidence of grade ≥2 pneumonitis was 12.5% in all patients treated, and 14.3% among the subset of patients treated with 54 Gy in 3 Fx. A total of two grade 3 toxicities were seen as one grade 5 toxicity in a patient treated for recurrence after pneumonectomy. Conclusions: Treating both central and peripheral lung lesions with SBRT in consecutive daily fractions in this cohort was well tolerated and did not cause excessive early pulmonary toxicity.

AB - Background and purpose: Identify the incidence of early pulmonary toxicity in a cohort of patients treated with lung stereotactic body radiation therapy (SBRT) on consecutive treatment days. Material and methods: A total of 88 lesions in 84 patients were treated with SBRT in consecutive daily fractions (Fx) for medically inoperable non-small cell lung cancer or metastasis. The incidence of pneumonitis was evaluated and graded according to the NCI CTCAE v3.0. Results: With a median follow-up of 15.8 months (range 2.5-28.6), the median age at SBRT was 71.8 years (range 23.8-87.8). 47 lesions were centrally located and 41 were peripheral. Most central lesions were treated with 48 Gy in 4 Fx, and most peripheral lesions with 54 Gy in 3 Fx. The incidence of grade ≥2 pneumonitis was 12.5% in all patients treated, and 14.3% among the subset of patients treated with 54 Gy in 3 Fx. A total of two grade 3 toxicities were seen as one grade 5 toxicity in a patient treated for recurrence after pneumonectomy. Conclusions: Treating both central and peripheral lung lesions with SBRT in consecutive daily fractions in this cohort was well tolerated and did not cause excessive early pulmonary toxicity.

KW - Lung neoplasms

KW - Non-small cell lung carcinoma

KW - Radiation pneumonitis

KW - Radiotherapy

KW - Stereotactic body radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=79958079919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958079919&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2011.04.002

DO - 10.1016/j.radonc.2011.04.002

M3 - Article

C2 - 21571384

AN - SCOPUS:79958079919

VL - 99

SP - 166

EP - 171

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -